UNICREDIT BANK/CALL/ROCHE GS/320/0.1/18.12.24 Share Price

Warrant

DE000HC7P3Z2

Market Closed - BOERSE MUENCHEN 01:15:32 18/05/2024 am IST
0.07 EUR +16.67% Intraday chart for UNICREDIT BANK/CALL/ROCHE GS/320/0.1/18.12.24
Current month+84.21%
1 month+29.63%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
17/24/17 0.07 +16.67%
16/24/16 0.06 +36.36%
15/24/15 0.044 +15.79%
14/24/14 0.038 -15.56%
13/24/13 0.045 -2.17%

Real-time BOERSE MUENCHEN

Last update May 18, 2024 at 01:15 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer UniCredit UniCredit
WKN HC7P3Z
ISINDE000HC7P3Z2
Date issued 26/06/2023
Strike 320 CHF
Maturity 18/12/2024 (214 Days)
Parity 10 : 1
Emission price 1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.95
Lowest since issue 0.001

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
237.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+17.84%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW